Approval · Notice of Compliance 35126 · 2025
NDUVRA: Notice of Compliance 35126
Issued April 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35126
- Date
- April 4, 2025
- Company
- Dermavant Sciences Gmbh
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NDUVRA | 02448254 | Marketed |
Medicinal ingredients
- TAPINAROF 1 PER